nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.189	1	CiPCiCtD
Dexamethasone—Prednisone—prostate cancer	0.127	1	CrCtD
Dexamethasone—breast cancer—Estradiol valerate/Dienogest—prostate cancer	0.0418	0.244	CpDpCtD
Dexamethasone—breast cancer—Estrone—prostate cancer	0.0418	0.244	CpDpCtD
Dexamethasone—CYP3A43—prostate cancer	0.0383	0.238	CbGaD
Dexamethasone—breast cancer—Estradiol—prostate cancer	0.0317	0.185	CpDpCtD
Dexamethasone—breast cancer—Conjugated Estrogens—prostate cancer	0.0317	0.185	CpDpCtD
Dexamethasone—ANXA1—prostate cancer	0.0302	0.188	CbGaD
Dexamethasone—breast cancer—Ethinyl Estradiol—prostate cancer	0.024	0.14	CpDpCtD
Dexamethasone—CYP17A1—prostate cancer	0.0174	0.108	CbGaD
Dexamethasone—CYP17A1—Abiraterone—prostate cancer	0.0159	0.0983	CbGbCtD
Dexamethasone—Testolactone—Estrone—prostate cancer	0.0153	0.161	CrCrCtD
Dexamethasone—CYP4A11—Estrone—prostate cancer	0.0133	0.0822	CbGbCtD
Dexamethasone—CYP1B1—prostate cancer	0.012	0.075	CbGaD
Dexamethasone—CYP3A5—prostate cancer	0.00959	0.0597	CbGaD
Dexamethasone—CYP2A6—prostate cancer	0.00928	0.0578	CbGaD
Dexamethasone—CYP19A1—prostate cancer	0.00884	0.055	CbGaD
Dexamethasone—CYP1B1—Flutamide—prostate cancer	0.00765	0.0472	CbGbCtD
Dexamethasone—NR3C1—prostate cancer	0.00716	0.0446	CbGaD
Dexamethasone—CYP2E1—prostate cancer	0.00659	0.041	CbGaD
Dexamethasone—CYP2C19—prostate cancer	0.00653	0.0406	CbGaD
Dexamethasone—CYP1A1—prostate cancer	0.0065	0.0405	CbGaD
Dexamethasone—NOS2—Doxorubicin—prostate cancer	0.00593	0.0366	CbGbCtD
Dexamethasone—CYP1B1—Estrone—prostate cancer	0.00553	0.0341	CbGbCtD
Dexamethasone—ABCB11—Ethinyl Estradiol—prostate cancer	0.00493	0.0304	CbGbCtD
Dexamethasone—CYP3A4—prostate cancer	0.00415	0.0258	CbGaD
Dexamethasone—PTGS2—prostate cancer	0.00406	0.0253	CbGaD
Dexamethasone—Prednicarbate—Prednisone—prostate cancer	0.00397	0.0419	CrCrCtD
Dexamethasone—Testolactone—Prednisone—prostate cancer	0.00397	0.0419	CrCrCtD
Dexamethasone—Fluocortolone—Prednisone—prostate cancer	0.00385	0.0407	CrCrCtD
Dexamethasone—Alclometasone—Prednisone—prostate cancer	0.00375	0.0396	CrCrCtD
Dexamethasone—Amcinonide—Prednisone—prostate cancer	0.00365	0.0385	CrCrCtD
Dexamethasone—Budesonide—Prednisone—prostate cancer	0.00365	0.0385	CrCrCtD
Dexamethasone—Diflorasone—Prednisone—prostate cancer	0.00355	0.0375	CrCrCtD
Dexamethasone—Flunisolide—Prednisone—prostate cancer	0.00355	0.0375	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisone—prostate cancer	0.00355	0.0375	CrCrCtD
Dexamethasone—Desonide—Prednisone—prostate cancer	0.00355	0.0375	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisone—prostate cancer	0.00355	0.0375	CrCrCtD
Dexamethasone—SLCO1A2—Estrone—prostate cancer	0.00351	0.0217	CbGbCtD
Dexamethasone—Paramethasone—Prednisone—prostate cancer	0.00346	0.0366	CrCrCtD
Dexamethasone—Desoximetasone—Prednisone—prostate cancer	0.00338	0.0357	CrCrCtD
Dexamethasone—CYP1A1—Flutamide—prostate cancer	0.00336	0.0207	CbGbCtD
Dexamethasone—Triamcinolone—Prednisone—prostate cancer	0.0033	0.0349	CrCrCtD
Dexamethasone—Loteprednol—Prednisone—prostate cancer	0.0033	0.0349	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Prednisone—prostate cancer	0.0033	0.0349	CrCrCtD
Dexamethasone—Fluorometholone—Prednisone—prostate cancer	0.0033	0.0349	CrCrCtD
Dexamethasone—Mometasone—Prednisone—prostate cancer	0.0033	0.0349	CrCrCtD
Dexamethasone—CYP1B1—Mitoxantrone—prostate cancer	0.00329	0.0203	CbGbCtD
Dexamethasone—Rimexolone—Prednisone—prostate cancer	0.00322	0.0341	CrCrCtD
Dexamethasone—Betamethasone—Prednisone—prostate cancer	0.00322	0.0341	CrCrCtD
Dexamethasone—CYP1B1—Estradiol—prostate cancer	0.00318	0.0196	CbGbCtD
Dexamethasone—Methylprednisolone—Prednisone—prostate cancer	0.00308	0.0326	CrCrCtD
Dexamethasone—Prednisolone—Prednisone—prostate cancer	0.00302	0.0319	CrCrCtD
Dexamethasone—Hydrocortisone—Prednisone—prostate cancer	0.0029	0.0306	CrCrCtD
Dexamethasone—ABCG2—Cabazitaxel—prostate cancer	0.00269	0.0166	CbGbCtD
Dexamethasone—ABCG2—Estrone—prostate cancer	0.00263	0.0162	CbGbCtD
Dexamethasone—ABCC2—Ethinyl Estradiol—prostate cancer	0.00259	0.016	CbGbCtD
Dexamethasone—CYP1A1—Estrone—prostate cancer	0.00243	0.015	CbGbCtD
Dexamethasone—CYP2C8—Nilutamide—prostate cancer	0.00234	0.0144	CbGbCtD
Dexamethasone—SLCO1A2—Conjugated Estrogens—prostate cancer	0.00229	0.0142	CbGbCtD
Dexamethasone—SLCO1A2—Estradiol—prostate cancer	0.00201	0.0124	CbGbCtD
Dexamethasone—CYP3A5—Flutamide—prostate cancer	0.00201	0.0124	CbGbCtD
Dexamethasone—NR3C1—Prednisone—prostate cancer	0.00201	0.0124	CbGbCtD
Dexamethasone—CYP2C19—Bicalutamide—prostate cancer	0.00196	0.0121	CbGbCtD
Dexamethasone—CYP2C19—Nilutamide—prostate cancer	0.00196	0.0121	CbGbCtD
Dexamethasone—CYP2C8—Abiraterone—prostate cancer	0.00194	0.012	CbGbCtD
Dexamethasone—ABCC2—Conjugated Estrogens—prostate cancer	0.0019	0.0117	CbGbCtD
Dexamethasone—CYP1B1—Docetaxel—prostate cancer	0.0019	0.0117	CbGbCtD
Dexamethasone—CYP2E1—Estrone—prostate cancer	0.00187	0.0116	CbGbCtD
Dexamethasone—CYP2B6—Estrone—prostate cancer	0.00185	0.0114	CbGbCtD
Dexamethasone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0018	0.0111	CbGbCtD
Dexamethasone—SLCO1A2—Prednisone—prostate cancer	0.00173	0.0107	CbGbCtD
Dexamethasone—ABCG2—Conjugated Estrogens—prostate cancer	0.00172	0.0106	CbGbCtD
Dexamethasone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00165	0.0102	CbGbCtD
Dexamethasone—CYP2C9—Nilutamide—prostate cancer	0.00163	0.0101	CbGbCtD
Dexamethasone—CYP2C9—Bicalutamide—prostate cancer	0.00163	0.0101	CbGbCtD
Dexamethasone—CYP2C19—Flutamide—prostate cancer	0.00163	0.01	CbGbCtD
Dexamethasone—ABCG2—Mitoxantrone—prostate cancer	0.00156	0.00965	CbGbCtD
Dexamethasone—ABCG2—Estradiol—prostate cancer	0.00151	0.00932	CbGbCtD
Dexamethasone—CYP2D6—Bicalutamide—prostate cancer	0.00149	0.0092	CbGbCtD
Dexamethasone—CYP3A5—Cabazitaxel—prostate cancer	0.00149	0.0092	CbGbCtD
Dexamethasone—ABCB1—Estramustine—prostate cancer	0.00147	0.00908	CbGbCtD
Dexamethasone—CYP3A5—Estrone—prostate cancer	0.00146	0.00899	CbGbCtD
Dexamethasone—CYP2C8—Cabazitaxel—prostate cancer	0.00143	0.00884	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—prostate cancer	0.00141	0.00873	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—prostate cancer	0.00141	0.00873	CbGbCtD
Dexamethasone—CYP1A1—Estradiol—prostate cancer	0.00139	0.0086	CbGbCtD
Dexamethasone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00125	0.00771	CbGbCtD
Dexamethasone—CYP2D6—Abiraterone—prostate cancer	0.00124	0.00763	CbGbCtD
Dexamethasone—CYP3A7—Estradiol—prostate cancer	0.00112	0.00688	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00112	0.00688	CbGbCtD
Dexamethasone—CYP2E1—Mitoxantrone—prostate cancer	0.00111	0.00688	CbGbCtD
Dexamethasone—ABCC2—Etoposide—prostate cancer	0.00109	0.00673	CbGbCtD
Dexamethasone—PTGS2—Etoposide—prostate cancer	0.00108	0.00665	CbGbCtD
Dexamethasone—ABCC2—Docetaxel—prostate cancer	0.000998	0.00616	CbGbCtD
Dexamethasone—ABCG2—Etoposide—prostate cancer	0.000986	0.00609	CbGbCtD
Dexamethasone—CYP2C9—Estrone—prostate cancer	0.000977	0.00603	CbGbCtD
Dexamethasone—ABCB1—Cabazitaxel—prostate cancer	0.00097	0.00599	CbGbCtD
Dexamethasone—CYP3A4—Bicalutamide—prostate cancer	0.000948	0.00585	CbGbCtD
Dexamethasone—ABCB1—Estrone—prostate cancer	0.000948	0.00585	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—prostate cancer	0.000902	0.00557	CbGbCtD
Dexamethasone—CYP3A4—Estramustine—prostate cancer	0.000881	0.00544	CbGbCtD
Dexamethasone—ABCB1—Ethinyl Estradiol—prostate cancer	0.000845	0.00522	CbGbCtD
Dexamethasone—CYP3A5—Estradiol—prostate cancer	0.000837	0.00516	CbGbCtD
Dexamethasone—CYP2C8—Estradiol—prostate cancer	0.000804	0.00497	CbGbCtD
Dexamethasone—CYP3A4—Abiraterone—prostate cancer	0.000786	0.00485	CbGbCtD
Dexamethasone—CYP3A4—Flutamide—prostate cancer	0.000786	0.00485	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—prostate cancer	0.000744	0.00459	CbGbCtD
Dexamethasone—CYP2C9—Capecitabine—prostate cancer	0.00074	0.00457	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—prostate cancer	0.000703	0.00434	CbGbCtD
Dexamethasone—CYP19A1—semen—prostate cancer	0.000684	0.0547	CbGeAlD
Dexamethasone—CYP2C19—Estradiol—prostate cancer	0.000675	0.00417	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—prostate cancer	0.000672	0.00415	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.000666	0.00411	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—prostate cancer	0.000666	0.00411	CbGbCtD
Dexamethasone—ABCB1—Conjugated Estrogens—prostate cancer	0.00062	0.00383	CbGbCtD
Dexamethasone—CYP3A4—Cabazitaxel—prostate cancer	0.000581	0.00359	CbGbCtD
Dexamethasone—CYP2C19—Prednisone—prostate cancer	0.00058	0.00358	CbGbCtD
Dexamethasone—CYP3A4—Estrone—prostate cancer	0.000568	0.00351	CbGbCtD
Dexamethasone—ABCB1—Mitoxantrone—prostate cancer	0.000564	0.00348	CbGbCtD
Dexamethasone—CYP2C9—Estradiol—prostate cancer	0.000561	0.00346	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—prostate cancer	0.000546	0.00337	CbGbCtD
Dexamethasone—ABCB1—Estradiol—prostate cancer	0.000544	0.00336	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—prostate cancer	0.000525	0.00324	CbGbCtD
Dexamethasone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000506	0.00312	CbGbCtD
Dexamethasone—CYP3A5—Docetaxel—prostate cancer	0.0005	0.00309	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—prostate cancer	0.000473	0.00292	CbGbCtD
Dexamethasone—ABCB1—Prednisone—prostate cancer	0.000468	0.00289	CbGbCtD
Dexamethasone—CYP2C19—urine—prostate cancer	0.000392	0.0313	CbGeAlD
Dexamethasone—CYP3A4—Conjugated Estrogens—prostate cancer	0.000372	0.00229	CbGbCtD
Dexamethasone—ABCB1—Etoposide—prostate cancer	0.000356	0.00219	CbGbCtD
Dexamethasone—CYP4A11—renal system—prostate cancer	0.000341	0.0272	CbGeAlD
Dexamethasone—CYP3A4—Mitoxantrone—prostate cancer	0.000338	0.00208	CbGbCtD
Dexamethasone—CYP3A4—Estradiol—prostate cancer	0.000326	0.00201	CbGbCtD
Dexamethasone—ABCB1—Docetaxel—prostate cancer	0.000325	0.00201	CbGbCtD
Dexamethasone—ANXA1—prostate gland—prostate cancer	0.000317	0.0253	CbGeAlD
Dexamethasone—CYP3A43—testis—prostate cancer	0.000309	0.0247	CbGeAlD
Dexamethasone—NR3C1—urine—prostate cancer	0.000306	0.0245	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—prostate cancer	0.000304	0.0243	CbGeAlD
Dexamethasone—CYP2C9—urine—prostate cancer	0.000304	0.0243	CbGeAlD
Dexamethasone—CYP2E1—urine—prostate cancer	0.000288	0.023	CbGeAlD
Dexamethasone—PLA2G1B—renal system—prostate cancer	0.000282	0.0225	CbGeAlD
Dexamethasone—CYP3A4—Prednisone—prostate cancer	0.000281	0.00173	CbGbCtD
Dexamethasone—ANXA1—seminal vesicle—prostate cancer	0.000268	0.0214	CbGeAlD
Dexamethasone—NR0B1—testis—prostate cancer	0.000256	0.0204	CbGeAlD
Dexamethasone—ABCB1—Doxorubicin—prostate cancer	0.000242	0.0015	CbGbCtD
Dexamethasone—ANXA1—epithelium—prostate cancer	0.000233	0.0186	CbGeAlD
Dexamethasone—CYP3A4—urine—prostate cancer	0.000232	0.0185	CbGeAlD
Dexamethasone—CYP2D6—Doxorubicin—prostate cancer	0.000228	0.00141	CbGbCtD
Dexamethasone—CYP2D6—urine—prostate cancer	0.000228	0.0182	CbGeAlD
Dexamethasone—CYP2A6—prostate gland—prostate cancer	0.000219	0.0175	CbGeAlD
Dexamethasone—ANXA1—renal system—prostate cancer	0.000216	0.0172	CbGeAlD
Dexamethasone—CYP3A4—Etoposide—prostate cancer	0.000213	0.00131	CbGbCtD
Dexamethasone—ANXA1—urethra—prostate cancer	0.000212	0.0169	CbGeAlD
Dexamethasone—NR3C2—prostate gland—prostate cancer	0.000205	0.0164	CbGeAlD
Dexamethasone—CYP3A4—Docetaxel—prostate cancer	0.000195	0.0012	CbGbCtD
Dexamethasone—CYP17A1—renal system—prostate cancer	0.000193	0.0154	CbGeAlD
Dexamethasone—PGR—prostate gland—prostate cancer	0.000191	0.0152	CbGeAlD
Dexamethasone—CYP2A6—seminal vesicle—prostate cancer	0.000185	0.0148	CbGeAlD
Dexamethasone—PLA2G1B—testis—prostate cancer	0.000182	0.0146	CbGeAlD
Dexamethasone—NR3C2—seminal vesicle—prostate cancer	0.000173	0.0139	CbGeAlD
Dexamethasone—CYP19A1—prostate gland—prostate cancer	0.000172	0.0137	CbGeAlD
Dexamethasone—ABCC2—prostate gland—prostate cancer	0.000164	0.0131	CbGeAlD
Dexamethasone—ANXA1—bone marrow—prostate cancer	0.000163	0.013	CbGeAlD
Dexamethasone—CYP1B1—prostate gland—prostate cancer	0.00016	0.0128	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—prostate cancer	0.000145	0.000897	CbGbCtD
Dexamethasone—ABCB11—testis—prostate cancer	0.000142	0.0113	CbGeAlD
Dexamethasone—PGR—epithelium—prostate cancer	0.00014	0.0112	CbGeAlD
Dexamethasone—NR3C2—renal system—prostate cancer	0.00014	0.0112	CbGeAlD
Dexamethasone—ANXA1—testis—prostate cancer	0.00014	0.0111	CbGeAlD
Dexamethasone—NR3C2—urethra—prostate cancer	0.000137	0.011	CbGeAlD
Dexamethasone—CYP17A1—testis—prostate cancer	0.000125	0.00999	CbGeAlD
Dexamethasone—SLCO1A2—renal system—prostate cancer	0.00012	0.00957	CbGeAlD
Dexamethasone—ABCG2—prostate gland—prostate cancer	0.000119	0.00954	CbGeAlD
Dexamethasone—CYP11A1—testis—prostate cancer	0.000116	0.00929	CbGeAlD
Dexamethasone—ABCC2—renal system—prostate cancer	0.000112	0.00891	CbGeAlD
Dexamethasone—CYP3A5—prostate gland—prostate cancer	0.000111	0.00885	CbGeAlD
Dexamethasone—NR3C1—prostate gland—prostate cancer	0.00011	0.00878	CbGeAlD
Dexamethasone—CYP1B1—renal system—prostate cancer	0.000109	0.00873	CbGeAlD
Dexamethasone—CYP2E1—prostate gland—prostate cancer	0.000103	0.00826	CbGeAlD
Dexamethasone—ANXA1—lymph node—prostate cancer	0.000101	0.00808	CbGeAlD
Dexamethasone—ABCG2—seminal vesicle—prostate cancer	0.000101	0.00807	CbGeAlD
Dexamethasone—PTGS2—prostate gland—prostate cancer	9.52e-05	0.0076	CbGeAlD
Dexamethasone—NR3C1—seminal vesicle—prostate cancer	9.3e-05	0.00743	CbGeAlD
Dexamethasone—CYP17A1—lymph node—prostate cancer	9.06e-05	0.00724	CbGeAlD
Dexamethasone—NR3C2—testis—prostate cancer	9.03e-05	0.00722	CbGeAlD
Dexamethasone—Amcinonide—ANXA1—prostate cancer	8.83e-05	0.0783	CrCbGaD
Dexamethasone—CYP2E1—seminal vesicle—prostate cancer	8.75e-05	0.00698	CbGeAlD
Dexamethasone—CYP11A1—lymph node—prostate cancer	8.43e-05	0.00673	CbGeAlD
Dexamethasone—PGR—testis—prostate cancer	8.4e-05	0.00671	CbGeAlD
Dexamethasone—CYP2C8—renal system—prostate cancer	8.37e-05	0.00669	CbGeAlD
Dexamethasone—CYP1A1—epithelium—prostate cancer	8.33e-05	0.00665	CbGeAlD
Dexamethasone—NR3C1—epithelium—prostate cancer	8.08e-05	0.00646	CbGeAlD
Dexamethasone—PTGS2—seminal vesicle—prostate cancer	8.05e-05	0.00643	CbGeAlD
Dexamethasone—ABCG2—urethra—prostate cancer	8e-05	0.00639	CbGeAlD
Dexamethasone—SLCO1A2—testis—prostate cancer	7.74e-05	0.00618	CbGeAlD
Dexamethasone—CYP1A1—renal system—prostate cancer	7.73e-05	0.00617	CbGeAlD
Dexamethasone—CYP1A1—urethra—prostate cancer	7.59e-05	0.00606	CbGeAlD
Dexamethasone—CYP19A1—testis—prostate cancer	7.56e-05	0.00604	CbGeAlD
Dexamethasone—CYP3A5—renal system—prostate cancer	7.56e-05	0.00603	CbGeAlD
Dexamethasone—CYP2B6—renal system—prostate cancer	7.51e-05	0.006	CbGeAlD
Dexamethasone—NR3C1—renal system—prostate cancer	7.5e-05	0.00599	CbGeAlD
Dexamethasone—NR3C1—urethra—prostate cancer	7.37e-05	0.00588	CbGeAlD
Dexamethasone—ABCC2—testis—prostate cancer	7.21e-05	0.00576	CbGeAlD
Dexamethasone—CYP1B1—testis—prostate cancer	7.07e-05	0.00564	CbGeAlD
Dexamethasone—CYP2E1—renal system—prostate cancer	7.05e-05	0.00563	CbGeAlD
Dexamethasone—PTGS2—epithelium—prostate cancer	7e-05	0.00559	CbGeAlD
Dexamethasone—CYP2E1—urethra—prostate cancer	6.92e-05	0.00553	CbGeAlD
Dexamethasone—NR3C2—lymph node—prostate cancer	6.55e-05	0.00523	CbGeAlD
Dexamethasone—PTGS2—renal system—prostate cancer	6.49e-05	0.00518	CbGeAlD
Dexamethasone—PTGS2—urethra—prostate cancer	6.37e-05	0.00509	CbGeAlD
Dexamethasone—ABCG2—bone marrow—prostate cancer	6.15e-05	0.00491	CbGeAlD
Dexamethasone—PGR—lymph node—prostate cancer	6.09e-05	0.00486	CbGeAlD
Dexamethasone—ABCB1—prostate gland—prostate cancer	5.89e-05	0.0047	CbGeAlD
Dexamethasone—CYP3A4—renal system—prostate cancer	5.67e-05	0.00453	CbGeAlD
Dexamethasone—NR3C1—bone marrow—prostate cancer	5.67e-05	0.00453	CbGeAlD
Dexamethasone—CYP2D6—renal system—prostate cancer	5.58e-05	0.00446	CbGeAlD
Dexamethasone—CYP19A1—lymph node—prostate cancer	5.48e-05	0.00437	CbGeAlD
Dexamethasone—CYP2C8—testis—prostate cancer	5.41e-05	0.00432	CbGeAlD
Dexamethasone—ABCG2—testis—prostate cancer	5.26e-05	0.0042	CbGeAlD
Dexamethasone—ABCC2—lymph node—prostate cancer	5.23e-05	0.00418	CbGeAlD
Dexamethasone—CYP1B1—lymph node—prostate cancer	5.12e-05	0.00409	CbGeAlD
Dexamethasone—ABCB1—seminal vesicle—prostate cancer	4.98e-05	0.00398	CbGeAlD
Dexamethasone—PTGS2—bone marrow—prostate cancer	4.91e-05	0.00392	CbGeAlD
Dexamethasone—CYP2B6—testis—prostate cancer	4.85e-05	0.00388	CbGeAlD
Dexamethasone—NR3C1—testis—prostate cancer	4.85e-05	0.00387	CbGeAlD
Dexamethasone—CYP2E1—testis—prostate cancer	4.55e-05	0.00364	CbGeAlD
Dexamethasone—ABCB1—epithelium—prostate cancer	4.33e-05	0.00346	CbGeAlD
Dexamethasone—ABCB1—renal system—prostate cancer	4.01e-05	0.00321	CbGeAlD
Dexamethasone—ABCB1—urethra—prostate cancer	3.94e-05	0.00315	CbGeAlD
Dexamethasone—ABCG2—lymph node—prostate cancer	3.81e-05	0.00305	CbGeAlD
Dexamethasone—Hydrocortisone—ANXA1—prostate cancer	3.72e-05	0.033	CrCbGaD
Dexamethasone—CYP1A1—lymph node—prostate cancer	3.62e-05	0.00289	CbGeAlD
Dexamethasone—CYP2D6—testis—prostate cancer	3.61e-05	0.00288	CbGeAlD
Dexamethasone—Testolactone—CYP19A1—prostate cancer	3.55e-05	0.0315	CrCbGaD
Dexamethasone—NR3C1—lymph node—prostate cancer	3.51e-05	0.00281	CbGeAlD
Dexamethasone—PTGS2—lymph node—prostate cancer	3.04e-05	0.00243	CbGeAlD
Dexamethasone—ABCB1—bone marrow—prostate cancer	3.03e-05	0.00242	CbGeAlD
Dexamethasone—Difluprednate—NR3C1—prostate cancer	2.97e-05	0.0263	CrCbGaD
Dexamethasone—Clocortolone—NR3C1—prostate cancer	2.88e-05	0.0255	CrCbGaD
Dexamethasone—Prednicarbate—NR3C1—prostate cancer	2.88e-05	0.0255	CrCbGaD
Dexamethasone—Diflorasone—NR3C1—prostate cancer	2.72e-05	0.0241	CrCbGaD
Dexamethasone—Desonide—NR3C1—prostate cancer	2.72e-05	0.0241	CrCbGaD
Dexamethasone—Desoximetasone—NR3C1—prostate cancer	2.66e-05	0.0235	CrCbGaD
Dexamethasone—Loteprednol—NR3C1—prostate cancer	2.63e-05	0.0233	CrCbGaD
Dexamethasone—ABCB1—testis—prostate cancer	2.59e-05	0.00207	CbGeAlD
Dexamethasone—Fludrocortisone—AR—prostate cancer	2.59e-05	0.0229	CrCbGaD
Dexamethasone—Beclomethasone—CYP3A5—prostate cancer	2.48e-05	0.022	CrCbGaD
Dexamethasone—Fluoxymesterone—SHBG—prostate cancer	2.44e-05	0.0216	CrCbGaD
Dexamethasone—Flurandrenolide—NR3C1—prostate cancer	2.33e-05	0.0206	CrCbGaD
Dexamethasone—Flumethasone Pivalate—NR3C1—prostate cancer	2.29e-05	0.0203	CrCbGaD
Dexamethasone—Halobetasol Propionate—NR3C1—prostate cancer	2.25e-05	0.0199	CrCbGaD
Dexamethasone—Fluoxymesterone—AR—prostate cancer	2.14e-05	0.0189	CrCbGaD
Dexamethasone—Amcinonide—NR3C1—prostate cancer	2.09e-05	0.0185	CrCbGaD
Dexamethasone—Budesonide—NR3C1—prostate cancer	2.09e-05	0.0185	CrCbGaD
Dexamethasone—Fluticasone furoate—NR3C1—prostate cancer	2.05e-05	0.0182	CrCbGaD
Dexamethasone—Mometasone—NR3C1—prostate cancer	1.99e-05	0.0176	CrCbGaD
Dexamethasone—Rimexolone—NR3C1—prostate cancer	1.97e-05	0.0174	CrCbGaD
Dexamethasone—ABCB1—lymph node—prostate cancer	1.88e-05	0.0015	CbGeAlD
Dexamethasone—Beclomethasone—NR3C1—prostate cancer	1.85e-05	0.0164	CrCbGaD
Dexamethasone—Fluocinonide—NR3C1—prostate cancer	1.85e-05	0.0164	CrCbGaD
Dexamethasone—Alclometasone—NR3C1—prostate cancer	1.8e-05	0.016	CrCbGaD
Dexamethasone—Fluocinolone Acetonide—NR3C1—prostate cancer	1.8e-05	0.016	CrCbGaD
Dexamethasone—Flunisolide—NR3C1—prostate cancer	1.76e-05	0.0155	CrCbGaD
Dexamethasone—Clobetasol propionate—NR3C1—prostate cancer	1.76e-05	0.0155	CrCbGaD
Dexamethasone—Fludrocortisone—NR3C1—prostate cancer	1.76e-05	0.0155	CrCbGaD
Dexamethasone—Paramethasone—NR3C1—prostate cancer	1.73e-05	0.0154	CrCbGaD
Dexamethasone—Fluorometholone—NR3C1—prostate cancer	1.69e-05	0.015	CrCbGaD
Dexamethasone—Fluticasone Propionate—CYP3A5—prostate cancer	1.65e-05	0.0146	CrCbGaD
Dexamethasone—Fluoxymesterone—ESR1—prostate cancer	1.65e-05	0.0146	CrCbGaD
Dexamethasone—Methylprednisolone—NR3C1—prostate cancer	1.64e-05	0.0145	CrCbGaD
Dexamethasone—Clobetasol propionate—CYP1A1—prostate cancer	1.59e-05	0.0141	CrCbGaD
Dexamethasone—Prednisolone—CYP2A6—prostate cancer	1.49e-05	0.0132	CrCbGaD
Dexamethasone—Hydrocortisone—SHBG—prostate cancer	1.48e-05	0.0131	CrCbGaD
Dexamethasone—Fluoxymesterone—NR3C1—prostate cancer	1.45e-05	0.0128	CrCbGaD
Dexamethasone—Betamethasone—CYP19A1—prostate cancer	1.39e-05	0.0123	CrCbGaD
Dexamethasone—Triamcinolone—NR3C1—prostate cancer	1.38e-05	0.0122	CrCbGaD
Dexamethasone—Prednisone—NR3C1—prostate cancer	1.25e-05	0.0111	CrCbGaD
Dexamethasone—Fluticasone Propionate—NR3C1—prostate cancer	1.23e-05	0.0109	CrCbGaD
Dexamethasone—Budesonide—CYP3A4—prostate cancer	1.21e-05	0.0107	CrCbGaD
Dexamethasone—Fluticasone furoate—CYP3A4—prostate cancer	1.19e-05	0.0105	CrCbGaD
Dexamethasone—Hydrocortisone—CYP3A5—prostate cancer	1.18e-05	0.0105	CrCbGaD
Dexamethasone—Prednisolone—NR3C1—prostate cancer	1.15e-05	0.0102	CrCbGaD
Dexamethasone—Prednisone—CYP2C19—prostate cancer	1.14e-05	0.0101	CrCbGaD
Dexamethasone—Betamethasone—NR3C1—prostate cancer	1.13e-05	0.01	CrCbGaD
Dexamethasone—Alclometasone—CYP3A4—prostate cancer	1.04e-05	0.00926	CrCbGaD
Dexamethasone—Flunisolide—CYP3A4—prostate cancer	1.02e-05	0.00901	CrCbGaD
Dexamethasone—Paramethasone—CYP3A4—prostate cancer	1e-05	0.0089	CrCbGaD
Dexamethasone—Fluorometholone—CYP3A4—prostate cancer	9.81e-06	0.00869	CrCbGaD
Dexamethasone—Methylprednisolone—CYP3A4—prostate cancer	9.48e-06	0.0084	CrCbGaD
Dexamethasone—Diarrhoea—Estradiol—prostate cancer	9.21e-06	0.00022	CcSEcCtD
Dexamethasone—Convulsion—Docetaxel—prostate cancer	9.21e-06	0.00022	CcSEcCtD
Dexamethasone—Hypertension—Docetaxel—prostate cancer	9.17e-06	0.000219	CcSEcCtD
Dexamethasone—Erythema—Prednisone—prostate cancer	9.16e-06	0.000219	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—prostate cancer	9.07e-06	0.000216	CcSEcCtD
Dexamethasone—Myalgia—Docetaxel—prostate cancer	9.05e-06	0.000216	CcSEcCtD
Dexamethasone—Loss of consciousness—Capecitabine—prostate cancer	9.04e-06	0.000216	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—prostate cancer	9.01e-06	0.000215	CcSEcCtD
Dexamethasone—Asthenia—Mitoxantrone—prostate cancer	9e-06	0.000215	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—prostate cancer	9e-06	0.000215	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—prostate cancer	8.99e-06	0.000215	CcSEcCtD
Dexamethasone—Pain—Etoposide—prostate cancer	8.92e-06	0.000213	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—prostate cancer	8.92e-06	0.000213	CcSEcCtD
Dexamethasone—Dizziness—Estradiol—prostate cancer	8.9e-06	0.000212	CcSEcCtD
Dexamethasone—Hypertension—Capecitabine—prostate cancer	8.88e-06	0.000212	CcSEcCtD
Dexamethasone—Hydrocortisone—NR3C1—prostate cancer	8.82e-06	0.00781	CrCbGaD
Dexamethasone—Myalgia—Capecitabine—prostate cancer	8.76e-06	0.000209	CcSEcCtD
Dexamethasone—Anxiety—Capecitabine—prostate cancer	8.73e-06	0.000208	CcSEcCtD
Dexamethasone—Anaphylactic shock—Docetaxel—prostate cancer	8.67e-06	0.000207	CcSEcCtD
Dexamethasone—Oedema—Docetaxel—prostate cancer	8.67e-06	0.000207	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—prostate cancer	8.66e-06	0.000207	CcSEcCtD
Dexamethasone—Discomfort—Capecitabine—prostate cancer	8.65e-06	0.000207	CcSEcCtD
Dexamethasone—Infection—Docetaxel—prostate cancer	8.62e-06	0.000206	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—prostate cancer	8.61e-06	0.000206	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—prostate cancer	8.6e-06	0.000205	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—prostate cancer	8.59e-06	0.000205	CcSEcCtD
Dexamethasone—Diarrhoea—Mitoxantrone—prostate cancer	8.58e-06	0.000205	CcSEcCtD
Dexamethasone—Vomiting—Estradiol—prostate cancer	8.56e-06	0.000204	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—prostate cancer	8.53e-06	0.000204	CcSEcCtD
Dexamethasone—Shock—Docetaxel—prostate cancer	8.53e-06	0.000204	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—prostate cancer	8.5e-06	0.000203	CcSEcCtD
Dexamethasone—Ill-defined disorder—Prednisone—prostate cancer	8.5e-06	0.000203	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—prostate cancer	8.49e-06	0.000203	CcSEcCtD
Dexamethasone—Rash—Estradiol—prostate cancer	8.49e-06	0.000203	CcSEcCtD
Dexamethasone—Dermatitis—Estradiol—prostate cancer	8.48e-06	0.000202	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—prostate cancer	8.46e-06	0.000202	CcSEcCtD
Dexamethasone—Headache—Estradiol—prostate cancer	8.43e-06	0.000201	CcSEcCtD
Dexamethasone—Oedema—Capecitabine—prostate cancer	8.4e-06	0.0002	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—prostate cancer	8.38e-06	0.0002	CcSEcCtD
Dexamethasone—Angioedema—Prednisone—prostate cancer	8.37e-06	0.0002	CcSEcCtD
Dexamethasone—Infection—Capecitabine—prostate cancer	8.34e-06	0.000199	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—prostate cancer	8.32e-06	0.000199	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—prostate cancer	8.29e-06	0.000198	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—prostate cancer	8.28e-06	0.000197	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—prostate cancer	8.27e-06	0.000197	CcSEcCtD
Dexamethasone—Malaise—Prednisone—prostate cancer	8.26e-06	0.000197	CcSEcCtD
Dexamethasone—Shock—Capecitabine—prostate cancer	8.26e-06	0.000197	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—prostate cancer	8.25e-06	0.000197	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—prostate cancer	8.25e-06	0.000197	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—prostate cancer	8.25e-06	0.000197	CcSEcCtD
Dexamethasone—Nervous system disorder—Capecitabine—prostate cancer	8.23e-06	0.000197	CcSEcCtD
Dexamethasone—Vertigo—Prednisone—prostate cancer	8.23e-06	0.000197	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—prostate cancer	8.23e-06	0.000197	CcSEcCtD
Dexamethasone—Thrombocytopenia—Capecitabine—prostate cancer	8.22e-06	0.000196	CcSEcCtD
Dexamethasone—Syncope—Prednisone—prostate cancer	8.22e-06	0.000196	CcSEcCtD
Dexamethasone—Tachycardia—Capecitabine—prostate cancer	8.19e-06	0.000196	CcSEcCtD
Dexamethasone—Hyperhidrosis—Capecitabine—prostate cancer	8.12e-06	0.000194	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—prostate cancer	8.1e-06	0.000193	CcSEcCtD
Dexamethasone—Loss of consciousness—Prednisone—prostate cancer	8.05e-06	0.000192	CcSEcCtD
Dexamethasone—Anorexia—Capecitabine—prostate cancer	8e-06	0.000191	CcSEcCtD
Dexamethasone—Nausea—Estradiol—prostate cancer	8e-06	0.000191	CcSEcCtD
Dexamethasone—Triamcinolone—CYP3A4—prostate cancer	7.99e-06	0.00708	CrCbGaD
Dexamethasone—Vomiting—Mitoxantrone—prostate cancer	7.98e-06	0.00019	CcSEcCtD
Dexamethasone—Convulsion—Prednisone—prostate cancer	7.94e-06	0.000189	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—prostate cancer	7.93e-06	0.000189	CcSEcCtD
Dexamethasone—Hypertension—Prednisone—prostate cancer	7.91e-06	0.000189	CcSEcCtD
Dexamethasone—Rash—Mitoxantrone—prostate cancer	7.91e-06	0.000189	CcSEcCtD
Dexamethasone—Dermatitis—Mitoxantrone—prostate cancer	7.9e-06	0.000189	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.9e-06	0.000189	CcSEcCtD
Dexamethasone—Headache—Mitoxantrone—prostate cancer	7.86e-06	0.000188	CcSEcCtD
Dexamethasone—Hypotension—Capecitabine—prostate cancer	7.85e-06	0.000187	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—prostate cancer	7.84e-06	0.000187	CcSEcCtD
Dexamethasone—Triamcinolone—PTGS2—prostate cancer	7.83e-06	0.00693	CrCbGaD
Dexamethasone—Myalgia—Prednisone—prostate cancer	7.8e-06	0.000186	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—prostate cancer	7.79e-06	0.000186	CcSEcCtD
Dexamethasone—Anxiety—Prednisone—prostate cancer	7.77e-06	0.000186	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—prostate cancer	7.76e-06	0.000185	CcSEcCtD
Dexamethasone—Discomfort—Prednisone—prostate cancer	7.71e-06	0.000184	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—prostate cancer	7.69e-06	0.000184	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—prostate cancer	7.66e-06	0.000183	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.65e-06	0.000183	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—prostate cancer	7.63e-06	0.000182	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—prostate cancer	7.62e-06	0.000182	CcSEcCtD
Dexamethasone—Insomnia—Capecitabine—prostate cancer	7.59e-06	0.000181	CcSEcCtD
Dexamethasone—Paraesthesia—Capecitabine—prostate cancer	7.54e-06	0.00018	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—prostate cancer	7.54e-06	0.00018	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Docetaxel—prostate cancer	7.49e-06	0.000179	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—prostate cancer	7.49e-06	0.000179	CcSEcCtD
Dexamethasone—Anaphylactic shock—Prednisone—prostate cancer	7.48e-06	0.000178	CcSEcCtD
Dexamethasone—Oedema—Prednisone—prostate cancer	7.48e-06	0.000178	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—prostate cancer	7.48e-06	0.000178	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—prostate cancer	7.47e-06	0.000178	CcSEcCtD
Dexamethasone—Nausea—Mitoxantrone—prostate cancer	7.45e-06	0.000178	CcSEcCtD
Dexamethasone—Infection—Prednisone—prostate cancer	7.43e-06	0.000177	CcSEcCtD
Dexamethasone—Pain—Docetaxel—prostate cancer	7.42e-06	0.000177	CcSEcCtD
Dexamethasone—Dyspepsia—Capecitabine—prostate cancer	7.39e-06	0.000176	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—prostate cancer	7.38e-06	0.000176	CcSEcCtD
Dexamethasone—Shock—Prednisone—prostate cancer	7.36e-06	0.000176	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—prostate cancer	7.36e-06	0.000176	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—prostate cancer	7.34e-06	0.000175	CcSEcCtD
Dexamethasone—Nervous system disorder—Prednisone—prostate cancer	7.33e-06	0.000175	CcSEcCtD
Dexamethasone—Tachycardia—Prednisone—prostate cancer	7.3e-06	0.000174	CcSEcCtD
Dexamethasone—Decreased appetite—Capecitabine—prostate cancer	7.3e-06	0.000174	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—prostate cancer	7.28e-06	0.000174	CcSEcCtD
Dexamethasone—Prednisone—CYP3A4—prostate cancer	7.25e-06	0.00642	CrCbGaD
Dexamethasone—Gastrointestinal disorder—Capecitabine—prostate cancer	7.25e-06	0.000173	CcSEcCtD
Dexamethasone—Fatigue—Capecitabine—prostate cancer	7.24e-06	0.000173	CcSEcCtD
Dexamethasone—Hyperhidrosis—Prednisone—prostate cancer	7.23e-06	0.000173	CcSEcCtD
Dexamethasone—Pain—Capecitabine—prostate cancer	7.18e-06	0.000171	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—prostate cancer	7.17e-06	0.000171	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—prostate cancer	7.15e-06	0.000171	CcSEcCtD
Dexamethasone—Fluticasone Propionate—CYP3A4—prostate cancer	7.15e-06	0.00633	CrCbGaD
Dexamethasone—Diarrhoea—Etoposide—prostate cancer	7.14e-06	0.00017	CcSEcCtD
Dexamethasone—Anorexia—Prednisone—prostate cancer	7.13e-06	0.00017	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—prostate cancer	7.12e-06	0.00017	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—prostate cancer	7.09e-06	0.000169	CcSEcCtD
Dexamethasone—Feeling abnormal—Capecitabine—prostate cancer	6.92e-06	0.000165	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—prostate cancer	6.91e-06	0.000165	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—prostate cancer	6.9e-06	0.000165	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Capecitabine—prostate cancer	6.87e-06	0.000164	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—prostate cancer	6.86e-06	0.000164	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—prostate cancer	6.86e-06	0.000164	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Prednisone—prostate cancer	6.81e-06	0.000163	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—prostate cancer	6.81e-06	0.000162	CcSEcCtD
Dexamethasone—Insomnia—Prednisone—prostate cancer	6.76e-06	0.000161	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—prostate cancer	6.73e-06	0.000161	CcSEcCtD
Dexamethasone—Paraesthesia—Prednisone—prostate cancer	6.72e-06	0.00016	CcSEcCtD
Dexamethasone—Prednisolone—CYP3A4—prostate cancer	6.68e-06	0.00592	CrCbGaD
Dexamethasone—Urticaria—Capecitabine—prostate cancer	6.67e-06	0.000159	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—prostate cancer	6.65e-06	0.000159	CcSEcCtD
Dexamethasone—Abdominal pain—Capecitabine—prostate cancer	6.64e-06	0.000158	CcSEcCtD
Dexamethasone—Body temperature increased—Capecitabine—prostate cancer	6.64e-06	0.000158	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—prostate cancer	6.63e-06	0.000158	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—prostate cancer	6.63e-06	0.000158	CcSEcCtD
Dexamethasone—Dyspepsia—Prednisone—prostate cancer	6.58e-06	0.000157	CcSEcCtD
Dexamethasone—Rash—Etoposide—prostate cancer	6.58e-06	0.000157	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—prostate cancer	6.57e-06	0.000157	CcSEcCtD
Dexamethasone—Betamethasone—CYP3A4—prostate cancer	6.55e-06	0.0058	CrCbGaD
Dexamethasone—Headache—Etoposide—prostate cancer	6.54e-06	0.000156	CcSEcCtD
Dexamethasone—Decreased appetite—Prednisone—prostate cancer	6.5e-06	0.000155	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—prostate cancer	6.46e-06	0.000154	CcSEcCtD
Dexamethasone—Fatigue—Prednisone—prostate cancer	6.45e-06	0.000154	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—prostate cancer	6.44e-06	0.000154	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—prostate cancer	6.43e-06	0.000153	CcSEcCtD
Dexamethasone—Betamethasone—PTGS2—prostate cancer	6.41e-06	0.00568	CrCbGaD
Dexamethasone—Loss of consciousness—Epirubicin—prostate cancer	6.3e-06	0.00015	CcSEcCtD
Dexamethasone—Asthenia—Docetaxel—prostate cancer	6.22e-06	0.000149	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—prostate cancer	6.21e-06	0.000148	CcSEcCtD
Dexamethasone—Nausea—Etoposide—prostate cancer	6.2e-06	0.000148	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—prostate cancer	6.19e-06	0.000148	CcSEcCtD
Dexamethasone—Feeling abnormal—Prednisone—prostate cancer	6.16e-06	0.000147	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—prostate cancer	6.15e-06	0.000147	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—prostate cancer	6.14e-06	0.000146	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Prednisone—prostate cancer	6.12e-06	0.000146	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—prostate cancer	6.1e-06	0.000146	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—prostate cancer	6.08e-06	0.000145	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—prostate cancer	6.03e-06	0.000144	CcSEcCtD
Dexamethasone—Asthenia—Capecitabine—prostate cancer	6.02e-06	0.000144	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—prostate cancer	5.98e-06	0.000143	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—prostate cancer	5.96e-06	0.000142	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—prostate cancer	5.95e-06	0.000142	CcSEcCtD
Dexamethasone—Urticaria—Prednisone—prostate cancer	5.94e-06	0.000142	CcSEcCtD
Dexamethasone—Pruritus—Capecitabine—prostate cancer	5.94e-06	0.000142	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—prostate cancer	5.93e-06	0.000142	CcSEcCtD
Dexamethasone—Abdominal pain—Prednisone—prostate cancer	5.91e-06	0.000141	CcSEcCtD
Dexamethasone—Body temperature increased—Prednisone—prostate cancer	5.91e-06	0.000141	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—prostate cancer	5.85e-06	0.00014	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—prostate cancer	5.85e-06	0.00014	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—prostate cancer	5.83e-06	0.000139	CcSEcCtD
Dexamethasone—Infection—Epirubicin—prostate cancer	5.81e-06	0.000139	CcSEcCtD
Dexamethasone—Shock—Epirubicin—prostate cancer	5.75e-06	0.000137	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—prostate cancer	5.75e-06	0.000137	CcSEcCtD
Dexamethasone—Diarrhoea—Capecitabine—prostate cancer	5.74e-06	0.000137	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—prostate cancer	5.74e-06	0.000137	CcSEcCtD
Dexamethasone—Dizziness—Docetaxel—prostate cancer	5.73e-06	0.000137	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—prostate cancer	5.73e-06	0.000137	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—prostate cancer	5.73e-06	0.000137	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—prostate cancer	5.71e-06	0.000136	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—prostate cancer	5.65e-06	0.000135	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—prostate cancer	5.65e-06	0.000135	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—prostate cancer	5.63e-06	0.000134	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—prostate cancer	5.58e-06	0.000133	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—prostate cancer	5.58e-06	0.000133	CcSEcCtD
Dexamethasone—Dizziness—Capecitabine—prostate cancer	5.55e-06	0.000133	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—prostate cancer	5.51e-06	0.000132	CcSEcCtD
Dexamethasone—Rash—Docetaxel—prostate cancer	5.47e-06	0.000131	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—prostate cancer	5.47e-06	0.00013	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—prostate cancer	5.46e-06	0.00013	CcSEcCtD
Dexamethasone—Headache—Docetaxel—prostate cancer	5.43e-06	0.00013	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—prostate cancer	5.41e-06	0.000129	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—prostate cancer	5.41e-06	0.000129	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—prostate cancer	5.38e-06	0.000128	CcSEcCtD
Dexamethasone—Asthenia—Prednisone—prostate cancer	5.37e-06	0.000128	CcSEcCtD
Dexamethasone—Vomiting—Capecitabine—prostate cancer	5.34e-06	0.000127	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.33e-06	0.000127	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—prostate cancer	5.32e-06	0.000127	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—prostate cancer	5.31e-06	0.000127	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—prostate cancer	5.3e-06	0.000126	CcSEcCtD
Dexamethasone—Rash—Capecitabine—prostate cancer	5.29e-06	0.000126	CcSEcCtD
Dexamethasone—Pruritus—Prednisone—prostate cancer	5.29e-06	0.000126	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—prostate cancer	5.29e-06	0.000126	CcSEcCtD
Dexamethasone—Dermatitis—Capecitabine—prostate cancer	5.29e-06	0.000126	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—prostate cancer	5.28e-06	0.000126	CcSEcCtD
Dexamethasone—Headache—Capecitabine—prostate cancer	5.26e-06	0.000126	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—prostate cancer	5.25e-06	0.000125	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—prostate cancer	5.23e-06	0.000125	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—prostate cancer	5.16e-06	0.000123	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—prostate cancer	5.15e-06	0.000123	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—prostate cancer	5.15e-06	0.000123	CcSEcCtD
Dexamethasone—Diarrhoea—Prednisone—prostate cancer	5.12e-06	0.000122	CcSEcCtD
Dexamethasone—Hydrocortisone—CYP3A4—prostate cancer	5.11e-06	0.00453	CrCbGaD
Dexamethasone—Decreased appetite—Epirubicin—prostate cancer	5.08e-06	0.000121	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—prostate cancer	5.06e-06	0.000121	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—prostate cancer	5.05e-06	0.000121	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—prostate cancer	5.04e-06	0.00012	CcSEcCtD
Dexamethasone—Pain—Epirubicin—prostate cancer	5e-06	0.000119	CcSEcCtD
Dexamethasone—Nausea—Capecitabine—prostate cancer	4.99e-06	0.000119	CcSEcCtD
Dexamethasone—Dizziness—Prednisone—prostate cancer	4.95e-06	0.000118	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.93e-06	0.000118	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—prostate cancer	4.9e-06	0.000117	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—prostate cancer	4.86e-06	0.000116	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—prostate cancer	4.82e-06	0.000115	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—prostate cancer	4.78e-06	0.000114	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—prostate cancer	4.76e-06	0.000114	CcSEcCtD
Dexamethasone—Vomiting—Prednisone—prostate cancer	4.76e-06	0.000113	CcSEcCtD
Dexamethasone—Rash—Prednisone—prostate cancer	4.72e-06	0.000113	CcSEcCtD
Dexamethasone—Dermatitis—Prednisone—prostate cancer	4.71e-06	0.000112	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—prostate cancer	4.7e-06	0.000112	CcSEcCtD
Dexamethasone—Headache—Prednisone—prostate cancer	4.69e-06	0.000112	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.67e-06	0.000112	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—prostate cancer	4.67e-06	0.000111	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—prostate cancer	4.65e-06	0.000111	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—prostate cancer	4.63e-06	0.00011	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—prostate cancer	4.62e-06	0.00011	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—prostate cancer	4.62e-06	0.00011	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—prostate cancer	4.46e-06	0.000106	CcSEcCtD
Dexamethasone—Nausea—Prednisone—prostate cancer	4.44e-06	0.000106	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—prostate cancer	4.43e-06	0.000106	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—prostate cancer	4.3e-06	0.000103	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—prostate cancer	4.28e-06	0.000102	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—prostate cancer	4.28e-06	0.000102	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—prostate cancer	4.2e-06	0.0001	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—prostate cancer	4.14e-06	9.88e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—prostate cancer	4e-06	9.55e-05	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—prostate cancer	3.88e-06	9.27e-05	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—prostate cancer	3.87e-06	9.23e-05	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—prostate cancer	3.83e-06	9.14e-05	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—prostate cancer	3.72e-06	8.88e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—prostate cancer	3.7e-06	8.84e-05	CcSEcCtD
Dexamethasone—Rash—Epirubicin—prostate cancer	3.69e-06	8.8e-05	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—prostate cancer	3.68e-06	8.79e-05	CcSEcCtD
Dexamethasone—Headache—Epirubicin—prostate cancer	3.66e-06	8.75e-05	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—prostate cancer	3.58e-06	8.54e-05	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—prostate cancer	3.47e-06	8.29e-05	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—prostate cancer	3.44e-06	8.21e-05	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—prostate cancer	3.41e-06	8.14e-05	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—prostate cancer	3.41e-06	8.14e-05	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—prostate cancer	3.39e-06	8.09e-05	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—prostate cancer	3.21e-06	7.67e-05	CcSEcCtD
Dexamethasone—CYP2A6—Metabolism—NOS3—prostate cancer	2.09e-07	5.17e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—prostate cancer	2.09e-07	5.16e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.08e-07	5.15e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—COMT—prostate cancer	2.08e-07	5.14e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—prostate cancer	2.07e-07	5.12e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—prostate cancer	2.07e-07	5.11e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—COMT—prostate cancer	2.06e-07	5.1e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAV1—prostate cancer	2.06e-07	5.09e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—prostate cancer	2.05e-07	5.07e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.05e-07	5.07e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.05e-07	5.06e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—prostate cancer	2.04e-07	5.05e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—JAK2—prostate cancer	2.04e-07	5.04e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ITPR1—prostate cancer	2.04e-07	5.04e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.04e-07	5.03e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—LPL—prostate cancer	2.03e-07	5.02e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.02e-07	4.99e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—prostate cancer	2.02e-07	4.99e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—prostate cancer	2.02e-07	4.99e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.02e-07	4.98e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARA—prostate cancer	2.01e-07	4.97e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—INS—prostate cancer	2e-07	4.95e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2e-07	4.95e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—prostate cancer	2e-07	4.94e-06	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—prostate cancer	2e-07	4.93e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.99e-07	4.92e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—prostate cancer	1.99e-07	4.92e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.99e-07	4.91e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.99e-07	4.91e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—LPL—prostate cancer	1.98e-07	4.9e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—prostate cancer	1.98e-07	4.88e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.97e-07	4.87e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.96e-07	4.85e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CREBBP—prostate cancer	1.96e-07	4.85e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—prostate cancer	1.96e-07	4.85e-06	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—prostate cancer	1.96e-07	4.84e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ACHE—prostate cancer	1.96e-07	4.83e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.96e-07	4.83e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ERCC2—prostate cancer	1.95e-07	4.81e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—prostate cancer	1.94e-07	4.78e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.93e-07	4.77e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.93e-07	4.77e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—prostate cancer	1.93e-07	4.76e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—prostate cancer	1.93e-07	4.76e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—INS—prostate cancer	1.93e-07	4.76e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.92e-07	4.73e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—prostate cancer	1.91e-07	4.73e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—prostate cancer	1.91e-07	4.72e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—prostate cancer	1.9e-07	4.7e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ERCC2—prostate cancer	1.9e-07	4.69e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAV1—prostate cancer	1.89e-07	4.67e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—prostate cancer	1.89e-07	4.66e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—prostate cancer	1.89e-07	4.66e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CREBBP—prostate cancer	1.89e-07	4.66e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—INS—prostate cancer	1.89e-07	4.66e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—INS—prostate cancer	1.88e-07	4.65e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.88e-07	4.64e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.88e-07	4.64e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.87e-07	4.62e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—LPL—prostate cancer	1.87e-07	4.62e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—prostate cancer	1.86e-07	4.6e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—LPL—prostate cancer	1.85e-07	4.58e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.85e-07	4.57e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CREBBP—prostate cancer	1.85e-07	4.56e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.84e-07	4.55e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—prostate cancer	1.84e-07	4.54e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—prostate cancer	1.83e-07	4.52e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—prostate cancer	1.83e-07	4.51e-06	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—prostate cancer	1.83e-07	4.51e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—prostate cancer	1.82e-07	4.5e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—prostate cancer	1.82e-07	4.49e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.81e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—prostate cancer	1.81e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.81e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARA—prostate cancer	1.8e-07	4.43e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.79e-07	4.42e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.79e-07	4.42e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.79e-07	4.42e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—prostate cancer	1.79e-07	4.41e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—INS—prostate cancer	1.78e-07	4.39e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.78e-07	4.38e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.76e-07	4.35e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NOS3—prostate cancer	1.76e-07	4.34e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—prostate cancer	1.75e-07	4.33e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARA—prostate cancer	1.75e-07	4.33e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.75e-07	4.33e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.75e-07	4.32e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CREBBP—prostate cancer	1.74e-07	4.3e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—prostate cancer	1.74e-07	4.29e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.72e-07	4.25e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—prostate cancer	1.72e-07	4.24e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NOS3—prostate cancer	1.69e-07	4.17e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAV1—prostate cancer	1.69e-07	4.17e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.68e-07	4.16e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.68e-07	4.15e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—prostate cancer	1.68e-07	4.14e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—prostate cancer	1.67e-07	4.13e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—prostate cancer	1.67e-07	4.13e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—prostate cancer	1.67e-07	4.12e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—prostate cancer	1.67e-07	4.12e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NOS3—prostate cancer	1.65e-07	4.09e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.65e-07	4.08e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARA—prostate cancer	1.65e-07	4.08e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NOS3—prostate cancer	1.65e-07	4.08e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAV1—prostate cancer	1.65e-07	4.07e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.64e-07	4.06e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.64e-07	4.04e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARA—prostate cancer	1.64e-07	4.04e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—INS—prostate cancer	1.63e-07	4.03e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NQO1—prostate cancer	1.62e-07	4.01e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—prostate cancer	1.62e-07	4.01e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.61e-07	3.98e-06	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—prostate cancer	1.6e-07	3.96e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TH—prostate cancer	1.6e-07	3.95e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CREBBP—prostate cancer	1.6e-07	3.94e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—prostate cancer	1.6e-07	3.94e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—prostate cancer	1.59e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NOS3—prostate cancer	1.56e-07	3.85e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.56e-07	3.85e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.56e-07	3.85e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAV1—prostate cancer	1.55e-07	3.83e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—prostate cancer	1.55e-07	3.83e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—prostate cancer	1.55e-07	3.82e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—prostate cancer	1.54e-07	3.81e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAV1—prostate cancer	1.54e-07	3.8e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.54e-07	3.8e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.53e-07	3.77e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.52e-07	3.76e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.51e-07	3.74e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—prostate cancer	1.51e-07	3.74e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—prostate cancer	1.51e-07	3.73e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GGT1—prostate cancer	1.51e-07	3.73e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.5e-07	3.71e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—prostate cancer	1.5e-07	3.7e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.49e-07	3.67e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—prostate cancer	1.48e-07	3.66e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.47e-07	3.63e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.46e-07	3.62e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—INS—prostate cancer	1.46e-07	3.59e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.44e-07	3.56e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NOS3—prostate cancer	1.43e-07	3.53e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—prostate cancer	1.43e-07	3.52e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CREBBP—prostate cancer	1.43e-07	3.52e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—prostate cancer	1.43e-07	3.52e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—INS—prostate cancer	1.42e-07	3.51e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.41e-07	3.49e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—RXRA—prostate cancer	1.41e-07	3.49e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.4e-07	3.46e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—prostate cancer	1.4e-07	3.46e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CREBBP—prostate cancer	1.39e-07	3.44e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—prostate cancer	1.39e-07	3.44e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—prostate cancer	1.39e-07	3.43e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—prostate cancer	1.37e-07	3.39e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—COMT—prostate cancer	1.36e-07	3.36e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—prostate cancer	1.36e-07	3.36e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.36e-07	3.35e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.35e-07	3.34e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—prostate cancer	1.35e-07	3.33e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—INS—prostate cancer	1.34e-07	3.31e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—prostate cancer	1.34e-07	3.3e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—prostate cancer	1.34e-07	3.3e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.33e-07	3.29e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—INS—prostate cancer	1.33e-07	3.28e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.32e-07	3.26e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—prostate cancer	1.32e-07	3.26e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.32e-07	3.26e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—prostate cancer	1.32e-07	3.25e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.31e-07	3.24e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.31e-07	3.23e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.3e-07	3.21e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—prostate cancer	1.3e-07	3.2e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—prostate cancer	1.29e-07	3.17e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.29e-07	3.17e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—prostate cancer	1.29e-07	3.17e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NOS3—prostate cancer	1.28e-07	3.15e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—prostate cancer	1.26e-07	3.11e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—prostate cancer	1.26e-07	3.11e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—prostate cancer	1.26e-07	3.1e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NOS3—prostate cancer	1.25e-07	3.08e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.25e-07	3.08e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—prostate cancer	1.24e-07	3.07e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.24e-07	3.07e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.23e-07	3.04e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LPL—prostate cancer	1.22e-07	3.02e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—prostate cancer	1.21e-07	2.99e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—prostate cancer	1.19e-07	2.93e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—prostate cancer	1.18e-07	2.92e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.18e-07	2.92e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.18e-07	2.91e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.18e-07	2.91e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NOS3—prostate cancer	1.17e-07	2.9e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.17e-07	2.89e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—prostate cancer	1.17e-07	2.88e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—prostate cancer	1.16e-07	2.88e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NOS3—prostate cancer	1.16e-07	2.87e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.15e-07	2.84e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—prostate cancer	1.14e-07	2.82e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—prostate cancer	1.14e-07	2.81e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.1e-07	2.72e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—prostate cancer	1.09e-07	2.69e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.08e-07	2.68e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARA—prostate cancer	1.08e-07	2.67e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.07e-07	2.65e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.07e-07	2.65e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.06e-07	2.63e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—prostate cancer	1.06e-07	2.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—prostate cancer	1.05e-07	2.59e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—prostate cancer	1.05e-07	2.58e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—prostate cancer	1.02e-07	2.51e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAV1—prostate cancer	1.02e-07	2.51e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—prostate cancer	9.94e-08	2.45e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—prostate cancer	9.89e-08	2.44e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—prostate cancer	9.71e-08	2.4e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—prostate cancer	9.65e-08	2.38e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—prostate cancer	9.62e-08	2.38e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—prostate cancer	9.51e-08	2.35e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—prostate cancer	9.48e-08	2.34e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—prostate cancer	9.37e-08	2.31e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—prostate cancer	9.31e-08	2.3e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—prostate cancer	9.29e-08	2.29e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—prostate cancer	9.28e-08	2.29e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.25e-08	2.28e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—prostate cancer	8.93e-08	2.21e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—prostate cancer	8.85e-08	2.19e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—prostate cancer	8.78e-08	2.17e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—INS—prostate cancer	8.75e-08	2.16e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CREBBP—prostate cancer	8.57e-08	2.12e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.13e-08	2.01e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—prostate cancer	8.08e-08	2e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.05e-08	1.99e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—prostate cancer	7.77e-08	1.92e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NOS3—prostate cancer	7.68e-08	1.9e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—prostate cancer	7.61e-08	1.88e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—prostate cancer	7.59e-08	1.87e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.18e-08	1.77e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—prostate cancer	7.17e-08	1.77e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.09e-08	1.75e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—prostate cancer	7.02e-08	1.73e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—prostate cancer	7.01e-08	1.73e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.61e-08	1.63e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—prostate cancer	6.57e-08	1.62e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.55e-08	1.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—prostate cancer	6.12e-08	1.51e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—prostate cancer	5.87e-08	1.45e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—prostate cancer	5.84e-08	1.44e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—prostate cancer	5.73e-08	1.41e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—prostate cancer	5.4e-08	1.33e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—prostate cancer	5.35e-08	1.32e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.32e-08	1.07e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—prostate cancer	3.53e-08	8.71e-07	CbGpPWpGaD
